Latest News

The market for Xin Point Holdings Limited's ( HKG:1571 ) shares didn't move much after it posted weak earnings...

Wondering if CubeSmart at US$40.25 is offering good value right now, or if the easy gains are already behind it. The stock has been relatively steady over the last year with a 0.1% return, but the 8.1% return over 30 days and 13.7% return year to date show that sentiment around the shares has shifted recently. Recent trading moves have picked up as investors reassess listed real estate and storage focused stocks more broadly, with CubeSmart part of that conversation. This has put more...

Wondering whether Lumo Kodit Oyj at €7.40 is starting to look interesting or still has more risk than reward? This article walks through what the current price might be implying about the stock's value. The stock has had a weak run recently, with a 7 day return of an 8.8% decline, a 30 day return of a 12.4% decline, and a 1 year return of a 28.4% decline, while the 5 year return sits at a 55.8% decline. Recent coverage has focused on Lumo Kodit Oyj as a Helsinki listed residential real...

A10 Networks, Inc. has already reported first-quarter 2026 results, with revenue of US$75.0 million and net income of US$12.03 million, while its board approved a US$0.06 quarterly dividend and the company continued share repurchases under its existing buyback program. The company also reiterated its full-year 2026 outlook for revenue and earnings growth, underscoring management confidence in ongoing demand for its networking and security solutions. We’ll now examine how A10’s reaffirmed...

Endeavour Mining (TSX:EDV) is in focus after its latest quarterly earnings showed higher sales and net income compared with a year earlier, even though gold production volumes for the period were lower. See our latest analysis for Endeavour Mining. That earnings release, combined with ongoing share buybacks and BlackRock’s voting stake moving to 13.03%, comes against a CA$87.76 share price and strong momentum, with a 29.0% year to date share price return and a multi year total shareholder...

If you are wondering whether Swarmer's current share price reflects its real value, the recent moves in the stock give you plenty to think about. After recent trading, Swarmer closed at US$27.90, with returns of a 27.2% decline over 7 days, a 39.4% decline over 30 days and a 10.0% decline year to date. This suggests a sharp reset in market expectations. Recent headlines around Swarmer have focused on its position within the broader capital goods sector and how investors are reassessing...

CVB Financial (NasdaqGS:CVBF) has completed its acquisition of Heritage Commerce Corp, creating a larger combined bank. The company has released pro forma financials for 2025 for the merged entity, giving investors a first look at the combined profile. This transaction marks a meaningful change in CVB Financial’s scale and business mix compared with its prior standalone position. CVB Financial, trading at $20.51, now reflects a business that is materially different from the one behind its...

Aris Mining (TSX:ARIS) is back in focus after reporting record Q1 2026 results, with sales of US$372.48 million, net income of US$97.61 million, and earnings per share of US$0.47 from continuing operations. See our latest analysis for Aris Mining. The stock has attracted fresh attention after the record Q1 update, with a 7 day share price return of 6.9% and a year to date share price return of 19.8% pointing to firm momentum. A very large 1 year total shareholder return suggests recent gains...

Investors may be wondering whether RingCentral's current share price reflects its true worth, or if the recent price action has left it mispriced in either direction. The stock last closed at US$45.39, with returns of 12.9% over 7 days, 19.5% over 30 days, 64.5% year to date, 70.5% over 1 year, 58.2% over 3 years, and an 80.9% decline over 5 years. This presents a mixed picture of strong rebounds alongside longer term losses. Recent coverage has focused on RingCentral's position as a...

If you are wondering whether PTC at around US$147.65 is priced attractively, this article walks through what the current valuation signals might mean for you. The stock has seen an 8.3% move over the last 7 days and 2.6% over the past month, but is still showing a 13.2% decline year to date and a 10.4% decline over the last year, which may catch the eye of investors weighing potential opportunity against recent sentiment. Recent coverage of PTC has focused on its role as a US software...

ABIVAX Société Anonyme (ENXTPA:ABVX) completed a $90 million transaction to repurchase all existing royalty certificates. The repurchased royalty certificates are being cancelled, removing future royalty obligations linked to them. This transaction simplifies the company’s capital structure ahead of potential commercialization of its pipeline. ABIVAX, listed as ENXTPA:ABVX, focuses on developing therapies in the biopharma space, where funding structures and future payment obligations can be...

Wondering if Scholar Rock Holding at around US$46.45 is giving you fair value or a potential opportunity? This article walks through the key numbers in plain language so you can judge for yourself. The stock has seen mixed recent returns, with a 0.3% decline over the last 7 days and a 6.9% decline over the last month, alongside gains of 8.5% year to date, 49.9% over 1 year and a very large 3 year return, plus a 63.3% gain over 5 years. These moves have come as investors weigh ongoing...

Niagen Bioscience (NAGE) is back on investors’ radar after reporting Q1 2026 results that exceeded consensus estimates, alongside the launch of its Niagen Plus telehealth platform and at-home prescription injection kits. See our latest analysis for Niagen Bioscience. Despite the upbeat Q1 report and new Niagen Plus initiatives, the stock’s recent momentum has been weak, with a 30 day share price return of a 6.26% decline and a year to date share price return of a 32.96% decline. The 3 year...

Investors may be wondering whether Evercore, at around US$331 per share, still offers value or whether most of the easy gains are already behind it. The stock has delivered a 3.1% move over the last week and 7.9% over the past month, while year to date it is at a 5.7% decline against a 54.6% return over the last year, a 225.1% return over three years, and 154.1% over five years. Recent coverage has focused on Evercore's role in major advisory mandates and its position within capital markets...

Wondering if Hercules Capital's share price really reflects what you are getting for your money? This breakdown walks through what the current market price might be missing or already pricing in. Recently, the stock closed at US$16.40, with returns of 2.2% over 7 days, 8.5% over 30 days, 4.0% over 1 year and 67.6% over both 3 and 5 years, while the year to date return sits at a 13.0% decline. These moves sit against a backdrop of ongoing interest in income focused business development...

Praxis Precision Medicines (NasdaqGS:PRAX) reported that the FDA accepted New Drug Applications for ulixacaltamide and relutrigine. The company is preparing for potential U.S. launches following these NDA acceptances. Praxis also highlighted clinical progress for elsunersen, adding to momentum across its late-stage pipeline. For readers tracking central nervous system drug developers, Praxis sits at an important point in its evolution, with ulixacaltamide and relutrigine moving into formal...

Summerset Group Holdings recently held an Analyst/Investor Day to provide a performance update, focusing on business conditions following the late-February Middle East conflict. The company’s decision to directly address geopolitical risks and their operational implications offered investors rare, real-time insight into management’s response framework. We will now examine how Summerset’s conflict-related performance update shapes its investment narrative, particularly around risk management...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Unsurprisingly, Shanghai Electric Group Co., Ltd.'s ( HKG:2727 ) stock price was strong on the back of its healthy...

EnGro Corporation Limited ( SGX:S44 ) is about to trade ex-dividend in the next 3 days. The ex-dividend date is usually...

Nippon Fine Chemical Co., Ltd. ( TSE:4362 ) just released a solid earnings report, and the stock displayed some...

Why the Bouri project progress matters for Saipem (BIT:SPM) Saipem (BIT:SPM) is back in focus after Mellitah Oil and Gas completed a key phase of the $1.565b Bouri gas project in Libya ahead of schedule, highlighting Saipem’s role in this large upstream contract. See our latest analysis for Saipem. Saipem’s €4.304 share price has pulled back with a 7 day share price return of 6.56% after a strong run, including a 90 day share price return of 37.16% and a 1 year total shareholder return of...

If you are wondering whether Gulfport Energy, at a last close of US$178.80, is attractively priced or if the easy gains are behind it, this article breaks down what the current share price might be implying about the stock's value. The stock has seen a 7.1% decline over the last week, a 13.9% decline over the last month, and a 13.3% decline year to date, set against a 94.6% return over the last 3 years and a 5.0% decline over the last year. Recent coverage has focused on Gulfport Energy's...

In early May 2026, Kits Eyecare Ltd. reported its first-quarter 2026 results, with revenue rising to C$57.47 million and net income improving to C$1.98 million, while guiding second-quarter revenue to a range of C$57.0 million to C$59.0 million. The quarter also marked the company’s fourteenth straight period of positive adjusted EBITDA and very rapid growth in its higher-margin glasses segment, underpinned by a one-time tariff refund that was reinvested into customer acquisition and brand...